DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

